Cardiovascular Diseases

PCI Not Effective in Stable Angina

A blinded, multicenter randomized trial of percutaneous coronary intervention (PCI) versus a sham procedure for angina relief in the UK revealed that in patients with medically treated angina and severe coronary stenosis, PCI did not increase exercise time or improve symptoms. 230 patients with ischemic symptoms and severe (≥70%) single-vessel stenosis were enrolled and received 6 weeks of medication optimization, 200 patients underwent randomization between Jan 6, 2014, and Aug 11, 2017. Lesions had mean area stenosis of 84·4%, fractional flow reserve of 0·69, and instantaneous wave-free ratio of 0·76. There was no significant difference in the primary endpoint of exercise time increment between groups (PCI minus placebo 16·6 s, 95% CI −8·9 to 42·0, p=0·200). The results are consistent with previous findings that PCI in stable lesions did not produce long-term improvements in outcome when compared to optimal medical therapy. PCI has been proven effective in acute coronary syndrome. Source: http://www.thelancet.com/

hyangiu

Recent Posts

Global Study of Stroke Risk Factors

A study revealed that stroke remains a major global health challenge, influenced by numerous risk…

2 days ago

Antidepressants Effective and Safe in Older Adults with Anxiety

A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…

3 days ago

Geographical Variation in Lipoprotein (a) Levels Among CHD Patients

A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…

2 weeks ago

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

3 weeks ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 weeks ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 month ago

This website uses cookies.